Why Phase II/III Service Providers Lose Bids

In Q2, 2020, ISR asked 146 respondents involved in outsourcing Phase II/III services what is the main reason a CRO may lose bids for Phase II/III work. High cost topped the list, capturing 37% of respondents’ votes. Followed by Lack of therapeutic experience (19%) and Lack of understanding of the trial outcomes (12%). For more information, follow the link to the Phase II/III Study Trends and Market Outlook (2020-2024) report preview.